IL6 and colorectal neoplasm: Five studies reported elevated levels of IL-6, a pleiotropic pro-inflammatory cytokine, in patients with higher phenotypic and deficit accumulation frailty across the breast, prostate, and colorectal tumors (26, 28, 31, 32, 36).